Categories

Sign Up to Receive the Latest Trading Tips and News from Prosper



December 17, 2018

Clovis Oncology (CLVS)

The US equities markets were quite depressed today, with most indexes firmly lower through most of the session. The S&P 500 etf SPY was down over -1.70%, the healthcare etf XLV was down over -2%, and the biotech etf IBB was down over -1%. Concern about rising interest rates appears to be one of the […]

Read Article
December 14, 2018

Let’s Talk Strategy, CME and McDonald’s

Stocks across the globe are losing ground after weak economic data from China and Europe (see below) fanned concerns of a worldwide slowdown. Traders had anticipated a “Santa Rally” might have arrived following a rough December start for equities, but current sentiment may now signal a dead-cat bounce. On the U.S. economic calendar for today […]

Read Article
December 14, 2018

Johnson & Johnson Face Decline

The US equities markets were bearish today overall, and two stocks in particular saw sharp declines. One stock was Johnson & Johnson (JNJ), which is obviously a major name in the healthcare sector. The company’s stock was down over -10% at one point during the session due to news that the company may have hidden […]

Read Article
December 13, 2018

Clovis Oncology Reports Positive Results

Clovis Oncology (CLVS) rose in trading today due to positive news on one of its products. The company’s Rubraca product received a positive opinion from CHMP as a maintenance treatment for women with relapsed ovarian cancer. CLVS shares were up over +4% as of the time this content was created. Here is a recap of […]

Read Article
December 11, 2018

Something Is Up With Corcept Therapeutics

Corcept Therapeutics Inc (CORT) rose sharply late in trading on Tuesday after a rumor hit the street. The rumor was that the company may have received some kind of patent approval, but no details were mentioned. Nevertheless, given the strength of the upward movement, it seems clear that the market is convinced that something strongly […]

Read Article
December 10, 2018

Can’t Keep A Good Market Down?

US equities markets engineered a major comeback after being hammered at the opening bell. The SPY ETF, which tracks the S&P 500, was down over 2% before reversing to become positive by the latter part of the session. The healthcare ETF XLV and the biotech ETF IBB both bounced back as well and were positive […]

Read Article
December 7, 2018

Tonix Pharmaceuticals Holding Corp Was Hammered

Tonix Pharmaceuticals Holding Corp (TNXP) was hammered after news hit today. The news was that the company would issue $15M in new stock at $3.50 per share. The company had previously stated it would issue new shares and had also recently completed a reverse split. The stock was trading above $5 per share just before […]

Read Article
December 6, 2018

If Volatility Is Your Thing, We Have A Market For You!

The equities markets were quite volatile today, with large plunges in the S&P and Dow Jones indexes both before and after today’s open. The Dow was down almost -800 points at one point during today, before retracing nearly 50% of those losses by the middle of the session. There were multiple factors alleged to be […]

Read Article
December 4, 2018

Novelion Therapeutics Inc. In the News Today

Novelion Therapeutics Inc. (NVLN) rose sharply after market close yesterday after a major shareholder advocated for the company to explore a potential sale to another company. Our classroom has had a position in NVLN for a while where we were looking for something like this to happen, but the move was short-lived so we were […]

Read Article
December 3, 2018

Tesaro Gets Bought

The equities markets had a slightly bullish inclination today. The healthcare Tesaro, Inc. (TSRO) was up over +58% today after news hit that the company was being bought out by GlaxoSmithKline (GSK). The buyout price is $75 per share in cash, which caused GSK stock to drop over -8%. Previously in mid-November, TSRO was up […]

Read Article